Atomistry » Magnesium » PDB 4qh0-4qpm » 4qlv
Atomistry »
  Magnesium »
    PDB 4qh0-4qpm »
      4qlv »

Magnesium in PDB 4qlv: Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17

Enzymatic activity of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17

All present enzymatic activity of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17:
3.4.25.1;

Protein crystallography data

The structure of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17, PDB code: 4qlv was solved by G.De Bruin, E.Huber, B.Xin, E.Van Rooden, K.Al-Ayed, K.Kim, A.Kisselev, C.Driessen, G.Van Der Marel, M.Groll, H.Overkleeft, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 15.00 / 2.90
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 136.040, 300.380, 146.520, 90.00, 112.97, 90.00
R / Rfree (%) 18.4 / 20.9

Magnesium Binding Sites:

The binding sites of Magnesium atom in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17 (pdb code 4qlv). This binding sites where shown within 5.0 Angstroms radius around Magnesium atom.
In total 8 binding sites of Magnesium where determined in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17, PDB code: 4qlv:
Jump to Magnesium binding site number: 1; 2; 3; 4; 5; 6; 7; 8;

Magnesium binding site 1 out of 8 in 4qlv

Go back to Magnesium Binding Sites List in 4qlv
Magnesium binding site 1 out of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 1 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17 within 5.0Å range:
probe atom residue distance (Å) B Occ
G:Mg301

b:63.4
occ:1.00
 O G:MET125 2.0 70.0 1.0
O G:TYR119 2.4 57.5 1.0
O G:ARG122 2.4 58.0 1.0
OG1 G:THR8 2.4 56.6 1.0
C G:MET125 3.3 64.0 1.0
CG2 G:THR8 3.4 45.5 1.0
CB G:THR8 3.5 47.5 1.0
C G:TYR119 3.5 58.8 1.0
C G:ARG122 3.6 61.5 1.0
O G:ALA123 3.7 63.0 1.0
CA G:ALA123 3.9 56.9 1.0
C G:ALA123 3.9 60.8 1.0
N G:MET125 4.1 59.0 1.0
N G:ALA123 4.2 60.0 1.0
N G:ARG126 4.2 56.9 1.0
CA G:MET125 4.2 64.7 1.0
CA G:TYR119 4.2 57.3 1.0
CA G:ARG126 4.3 55.5 1.0
N G:THR8 4.4 52.7 1.0
CA G:THR8 4.6 53.0 1.0
CB G:MET125 4.6 73.3 1.0
N G:THR120 4.6 55.5 1.0
CB G:TYR119 4.6 58.7 1.0
CD G:PRO127 4.7 41.6 1.0
N G:TYR124 4.7 65.7 1.0
N G:ARG122 4.7 58.2 1.0
C G:ARG126 4.8 55.2 1.0
CA G:ARG122 4.8 61.1 1.0
CA G:THR120 4.9 50.6 1.0
C G:THR120 4.9 52.5 1.0
N G:PRO127 5.0 49.3 1.0

Magnesium binding site 2 out of 8 in 4qlv

Go back to Magnesium Binding Sites List in 4qlv
Magnesium binding site 2 out of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 2 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17 within 5.0Å range:
probe atom residue distance (Å) B Occ
I:Mg301

b:52.0
occ:1.00
 O I:ASP177 2.4 63.2 1.0
O I:SER180 2.6 49.9 1.0
O I:ALA174 2.8 53.9 1.0
C I:ASP177 3.6 62.6 1.0
OXT I:ASP204 3.7 67.2 1.0
C I:SER180 3.8 54.4 1.0
C I:ALA174 3.9 61.3 1.0
CA I:ALA178 4.3 58.6 1.0
CA I:ASP175 4.3 69.4 1.0
N I:ALA178 4.4 60.7 1.0
C I:ALA178 4.4 56.4 1.0
N I:ASP175 4.5 63.9 1.0
O I:ALA178 4.6 63.6 1.0
C I:ASP175 4.6 66.0 1.0
O I:ASP175 4.6 70.5 1.0
C I:ASP204 4.6 68.8 1.0
N I:ASP177 4.6 63.1 1.0
O I:ASP204 4.6 70.1 1.0
N I:SER180 4.6 50.1 1.0
CA I:ASP177 4.7 64.0 1.0
NH1 Y:ARG19 4.7 80.4 1.0
NH2 Y:ARG19 4.7 88.5 1.0
CA I:GLY181 4.7 57.5 1.0
N I:GLY181 4.7 56.0 1.0
CA I:SER180 4.8 53.3 1.0
N I:LEU179 4.9 49.5 1.0
OD1 I:ASP175 4.9 65.5 1.0
CA I:ALA174 5.0 61.2 1.0

Magnesium binding site 3 out of 8 in 4qlv

Go back to Magnesium Binding Sites List in 4qlv
Magnesium binding site 3 out of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 3 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17 within 5.0Å range:
probe atom residue distance (Å) B Occ
K:Mg301

b:78.5
occ:1.00
 O W:ASP204 2.2 79.6 1.0
O K:ALA165 2.4 59.8 1.0
O K:ASP168 2.4 76.2 1.0
O K:SER171 2.9 66.5 1.0
C W:ASP204 3.0 78.7 1.0
C K:ASP168 3.3 71.4 1.0
O K:HIS166 3.5 56.0 1.0
CA W:ASP204 3.5 70.1 1.0
C K:ALA165 3.6 65.0 1.0
CA K:ALA169 3.6 63.7 1.0
N K:ALA169 3.8 70.2 1.0
C K:ALA169 3.9 64.7 1.0
O K:ALA169 3.9 62.8 1.0
C K:HIS166 4.0 60.3 1.0
OXT W:ASP204 4.0 82.8 1.0
CB W:ASP204 4.0 65.6 1.0
NH1 K:ARG19 4.1 92.4 1.0
C K:SER171 4.1 70.9 1.0
CA K:HIS166 4.4 61.9 1.0
N K:HIS166 4.4 64.7 1.0
N K:ASP168 4.4 64.8 1.0
CA K:ASP168 4.5 67.8 1.0
N K:SER171 4.5 66.2 1.0
C K:ARG167 4.6 61.3 1.0
CA K:ALA165 4.6 68.6 1.0
O K:ALA164 4.6 65.1 1.0
O K:ARG167 4.7 54.7 1.0
N K:ARG167 4.7 57.1 1.0
N K:TYR170 4.7 62.3 1.0
CZ K:ARG19 4.8 83.2 1.0
N W:ASP204 4.8 65.6 1.0
CA K:SER171 4.8 65.3 1.0
CB K:ALA169 5.0 55.4 1.0
NH2 K:ARG19 5.0 85.2 1.0

Magnesium binding site 4 out of 8 in 4qlv

Go back to Magnesium Binding Sites List in 4qlv
Magnesium binding site 4 out of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 4 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17 within 5.0Å range:
probe atom residue distance (Å) B Occ
N:Mg201

b:68.1
occ:1.00
 O N:SER169 2.8 61.1 1.0
O N:ILE163 2.8 55.9 1.0
O N:ASP166 3.3 56.8 1.0
NH1 N:ARG19 3.6 61.6 1.0
CD1 a:LEU34 3.7 59.1 1.0
C N:SER169 3.9 58.8 1.0
C N:ILE163 3.9 56.8 1.0
CZ N:ARG19 4.1 58.4 1.0
CG2 N:ILE163 4.1 54.5 1.0
CA N:GLY167 4.2 49.8 1.0
NH2 N:ARG19 4.2 54.9 1.0
C N:ASP166 4.3 52.6 1.0
CA N:GLY170 4.3 64.6 1.0
O N:GLY167 4.4 48.4 1.0
N N:GLY170 4.6 60.2 1.0
C N:GLY167 4.6 50.4 1.0
N N:GLY167 4.6 51.0 1.0
CA N:ILE163 4.7 55.8 1.0
O N:LYS164 4.9 60.4 1.0
N N:LYS164 4.9 63.5 1.0
CG a:LEU34 5.0 61.7 1.0
CA N:SER169 5.0 53.0 1.0
N N:SER169 5.0 54.8 1.0

Magnesium binding site 5 out of 8 in 4qlv

Go back to Magnesium Binding Sites List in 4qlv
Magnesium binding site 5 out of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 5 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17 within 5.0Å range:
probe atom residue distance (Å) B Occ
N:Mg202

b:78.3
occ:1.00
 OE1 H:GLN91 2.9 80.8 1.0
OD1 N:ASP51 3.2 50.4 1.0
O N:ASN92 3.3 68.9 1.0
OD2 N:ASP51 3.6 59.0 1.0
CG N:ASP51 3.8 58.0 1.0
CD H:GLN91 3.9 85.7 1.0
NE2 H:GLN91 4.1 94.1 1.0
C N:ASN92 4.5 67.5 1.0

Magnesium binding site 6 out of 8 in 4qlv

Go back to Magnesium Binding Sites List in 4qlv
Magnesium binding site 6 out of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 6 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17 within 5.0Å range:
probe atom residue distance (Å) B Occ
V:Mg301

b:68.4
occ:1.00
 O V:ASP166 2.3 66.1 1.0
O V:ILE163 2.5 64.6 1.0
OXT L:ASP222 2.5 72.2 1.0
O V:TRP164 2.9 68.4 1.0
C V:ASP166 3.0 65.4 1.0
C L:ASP222 3.1 75.2 1.0
C V:TRP164 3.3 65.5 1.0
N V:ASP166 3.3 57.4 1.0
C V:ILE163 3.5 67.9 1.0
O V:SER169 3.6 69.3 1.0
N V:LEU167 3.7 69.6 1.0
O L:ASP222 3.7 74.7 1.0
CA V:ASP166 3.8 57.5 1.0
N V:ASN165 3.9 64.4 1.0
CA L:ASP222 3.9 78.5 1.0
C V:ASN165 3.9 60.2 1.0
CA V:TRP164 3.9 63.7 1.0
CA V:LEU167 3.9 67.9 1.0
O V:GLY162 4.0 67.5 1.0
N V:TRP164 4.1 65.7 1.0
CA V:ASN165 4.3 61.4 1.0
CD2 V:LEU167 4.5 61.5 1.0
O L:ARG221 4.5 65.8 1.0
CD1 L:ILE35 4.6 72.8 1.0
O V:ASN165 4.6 58.7 1.0
CA V:ILE163 4.7 69.7 1.0
CB L:ASP222 4.8 81.7 1.0
C V:SER169 4.8 66.8 1.0
NH1 V:ARG19 4.8 0.5 1.0
C V:LEU167 4.8 64.0 1.0
CB V:ASP166 4.8 56.7 1.0
N L:ASP222 5.0 76.9 1.0

Magnesium binding site 7 out of 8 in 4qlv

Go back to Magnesium Binding Sites List in 4qlv
Magnesium binding site 7 out of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 7 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17 within 5.0Å range:
probe atom residue distance (Å) B Occ
Y:Mg301

b:57.8
occ:1.00
 O Y:ASP168 2.2 58.0 1.0
O I:ASP204 2.4 70.1 1.0
O Y:ALA165 2.5 53.8 1.0
O Y:SER171 2.8 66.7 1.0
C Y:ASP168 3.1 56.1 1.0
C I:ASP204 3.3 68.8 1.0
CA Y:ALA169 3.4 49.9 1.0
O Y:HIS166 3.6 58.1 1.0
N Y:ALA169 3.6 54.5 1.0
C Y:ALA165 3.6 50.9 1.0
C Y:ALA169 3.7 52.9 1.0
CA I:ASP204 3.8 65.6 1.0
O Y:ALA169 3.8 55.9 1.0
C Y:SER171 4.0 67.1 1.0
C Y:HIS166 4.1 55.7 1.0
NH1 Y:ARG19 4.1 80.4 1.0
CB I:ASP204 4.2 62.9 1.0
OXT I:ASP204 4.2 67.2 1.0
N Y:SER171 4.3 60.2 1.0
CA Y:ASP168 4.3 54.3 1.0
N Y:ASP168 4.3 58.4 1.0
N Y:HIS166 4.5 49.4 1.0
C Y:ARG167 4.5 59.2 1.0
N Y:TYR170 4.5 52.5 1.0
CA Y:HIS166 4.5 51.9 1.0
O Y:ALA164 4.6 65.0 1.0
CA Y:ALA165 4.6 52.3 1.0
O Y:ARG167 4.6 55.4 1.0
CA Y:SER171 4.7 61.9 1.0
N Y:ARG167 4.8 54.4 1.0
CZ Y:ARG19 4.8 78.7 1.0
CB Y:ALA169 4.8 48.2 1.0

Magnesium binding site 8 out of 8 in 4qlv

Go back to Magnesium Binding Sites List in 4qlv
Magnesium binding site 8 out of 8 in the Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 8 of Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17 within 5.0Å range:
probe atom residue distance (Å) B Occ
Z:Mg301

b:69.5
occ:1.00
 O Z:VAL198 2.7 63.9 1.0
O Z:THR192 2.8 82.6 1.0
O Z:HIS195 2.8 63.2 1.0
NH2 Z:ARG28 3.6 69.8 1.0
O Z:ASP222 3.8 72.0 1.0
C Z:VAL198 3.8 67.5 1.0
C Z:THR192 3.8 74.1 1.0
C Z:HIS195 3.8 67.6 1.0
O Z:ILE196 3.9 77.7 1.0
CA Z:ILE196 3.9 69.5 1.0
CG2 Z:THR192 4.1 69.7 1.0
C Z:ILE196 4.1 71.9 1.0
NH2 H:ARG19 4.1 76.4 1.0
CA Z:THR192 4.2 71.4 1.0
OD1 Z:ASP222 4.3 74.6 1.0
N Z:ILE196 4.3 68.3 1.0
N Z:VAL198 4.5 67.6 1.0
C Z:ASP222 4.7 78.3 1.0
CA Z:VAL198 4.7 66.5 1.0
N Z:GLY199 4.7 64.3 1.0
CB Z:THR192 4.8 72.2 1.0
CA Z:GLY199 4.8 61.9 1.0
CZ Z:ARG28 4.8 70.3 1.0
NH1 H:ARG19 4.8 75.5 1.0
CZ H:ARG19 4.9 73.2 1.0
N Z:GLN197 4.9 71.2 1.0
N Z:HIS195 5.0 68.4 1.0

Reference:

G.De Bruin, E.M.Huber, B.T.Xin, E.J.Van Rooden, K.Al-Ayed, K.B.Kim, A.F.Kisselev, C.Driessen, M.Van Der Stelt, G.A.Van Der Marel, M.Groll, H.S.Overkleeft. Structure-Based Design of Beta 1I or Beta 5I Specific Inhibitors of Human Immunoproteasomes J.Med.Chem. V. 57 6197 2014.
ISSN: ISSN 0022-2623
PubMed: 25006746
DOI: 10.1021/JM500716S
Page generated: Tue Aug 20 02:05:45 2024

Last articles

Zn in 9JPJ
Zn in 9JP7
Zn in 9JPK
Zn in 9JPL
Zn in 9GN6
Zn in 9GN7
Zn in 9GKU
Zn in 9GKW
Zn in 9GKX
Zn in 9GL0
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy